Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study

By Belpomme D.   Krakowski I.   Beauduin M.   Petit T.   Canon J.L.   Janssens J.   Gauthier S.   De Pauw A.   Moreau V.   Kayitalire L.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 32-38

Elsevier

Access to resources Recommend Favorite

Carboplatin Alone vs Carboplatin plus Epidoxorubicin as Second-Line Therapy for Cisplatin- or Carboplatin-Sensitive Ovarian Cancer

By Bolis G.   Scarfone G.   Giardina G.   Villa A.   Mangili G.   Melpignano M.   Presti M.   Tateo S.   Franchi M.   Parazzini F.   on behalf of the Associazione per la Ricerca in Ginecologia Oncologica ARGO 96 Study Group  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 3-9

Elsevier

Access to resources Recommend Favorite

Phase II Study of Intraperitoneal Cisplatin Plus Systemic Etoposide as Second-line Treatment in Patients With Small Volume Residual Ovarian Cancer

By de Jong R.S.   Willemse P.H.B.   Boonstra H.   de Vries E.G.E.   van der Graaf W.T.A.   Sleijfer D.T.   van der Zee A.G.J.   Mulder N.H.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 709-713

Elsevier

Access to resources Recommend Favorite

Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I-II Study

By Lorusso V.   Leone B.   Di Vagno G.   Manzione L.   Palmeri S.   Vallejo C.   Machiavelli M.   Nacci G.   Bilancia D.   Leonardi V.   Catino A.   Gargano G.   Loverro G.   Selvaggi L.   De Lena M.  

Gynecologic Oncology, Vol. 68, Iss. 2, 1998-02 ,pp. : 172-177

Elsevier

Access to resources Recommend Favorite

Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of mullerian origin

By Berkenblit A.   Tung N.   Kim Y.   Feyler H.   Niloff J.   Berghe K.V.D.   Cannistra S.A.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 486-493

Elsevier

Access to resources Recommend Favorite